| Name | MAX-40279 hemifumarate |
|---|---|
| Synonyms |
MAX-40279 hemifumate
Thieno[3,2-d]pyrimidin-2-amine, 7-(4-fluoro-2-methoxyphenyl)-6-methyl-N-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-, (2E)-2-butenedioate (2:1) |
| Description | MAX-40279 hemifumarate is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 hemifumarate has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032)[1]. |
|---|---|
| Related Catalog | |
| Target |
FLT3 and FGFR[1] |
| References |
[1]. Yuguang Wang, et al. Novel Therapeutic Methods. Patent WO2021180032A1. |
| Molecular Formula | C26H27FN6O5S |
|---|---|
| Molecular Weight | 554.59 |